Kanghong Pharmaceutical announces CNY 552.67m equity distribution

Chengdu Kanghong Pharmaceutical Group (SZSE:002773) announced its 2024 equity distribution plan, approved at the shareholders' meeting on May 21, 2025. The company will distribute a cash dividend of CNY 6.00 (tax inclusive) per 10 shares, totaling CNY 552,673,862.40 (tax inclusive), based on the total share capital of 921,123,104 shares as of April 25, 2025. The remaining undistributed profits will be carried forward. The equity registration date is set for June 5, 2025, with the ex-right and ex-dividend date on June 6, 2025. The company clarified adjustments for Hong Kong market investors, organizations with QFII or RQFII status, and individual shareholders with pre-initial public offering (IPO) restricted shares, with specific tax treatments detailed. A portion of cash dividends will be distributed by the company itself.